Most not too long ago, it's been determined that conolidine and the above derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in comparable areas as classical opioid receptors, it binds to the wide array of endogenous opioids. Not like most opioid receptors, this receptor acts to be a scavenger and won't activate a second mes